Mefloquine during the study. Mefloquine was the first Public-Private Venture (PPV) between the US Department of Defense and a pharmaceutical company. WRAIR transferred all its phase I and phase II clinical trial data to Hoffman LaRoche and Smith Kline. FDA approval as a treatment for malaria was swift. Most notably, phase III safety and tolerability trials were skipped. The drug was first approved and sold on a commercial basis in Switzerland in 1985. However, mefloquine was not approved by the FDA for prophylactic use until 1989. This approval was based primarily on compliance, while safety and tolerability were overlooked. Because of
Association for the Treatment of Sexual Abusers Association for the Treatment of Sexual Abusers The Association for the Treatment of Sexual Abusers (ATSA) is an international, multi-disciplinary, non-profit organization dedicated to making society safer by preventing sexual abuse. ATSA promotes sound research, evidence-based practice, informed public policy, and collaborative community strategies that lead to the effective assessment, treatment, and management of individuals who sexually abuse or are at risk to abuse. ATSA sets ethical and practice standards for treatment providers, and provides referrals. The association was incorporated in 1985 and has its headquarters in Beaverton, Oregon, United States. ATSA is an international organization focused on the prevention